For Employers
Smarter healthcare. Lower cost of care. Increased productivity. Happier workforce.
Employers represent more than 50% of the private healthcare market — yet most have limited visibility into what's actually driving their healthcare spend. Alva10 uses data analytics to identify drivers of healthcare spending gaps in your workforce population and deploys targeted solutions that reduce total cost of care and improve employee productivity.
50%+
of private healthcare market is employer-sponsored
5-10×
ROI on targeted diagnostic deployment
25%+
potential reduction in therapeutic spend
<5%
of healthcare spend goes to diagnostics today
The Challenge
Rising costs,
limited visibility, misaligned incentives
Employers are absorbing a growing share of healthcare costs — funding treatments and procedures that are often administered without the diagnostic clarity needed to know whether they'll work. Commercial insurance carriers operate under incentive structures that may not align with what's best for your employees or your bottom line.
Alva10 gives employers the data analytics and diagnostic infrastructure to change that — sourcing and implementing the right tools to assess risk, catch disease earlier, guide treatment decisions accurately, and eliminate spend on therapies that were never going to work.
Overtreating Without Diagnosis
Costly specialty drugs and biologics are frequently administered without the diagnostic tools needed to confirm the patient likely to respond — increasing spend with no clinical benefit.
Unscreened Risk in Your Population
Disease found late costs dramatically more to treat. Without accurate risk-based screening programs, high-risk employees go unidentified until they're already sick — and expensive.
No Clear ROI on Diagnostics
Even when employers want to enable better diagnostics, the challenges of identifying the right patients and implementing targeted solutions has been too labor intensive, until now.
Opaque Carrier Incentives
Commercial insurers may not prioritize coverage of diagnostics that assess risk, enable screening, or reduce therapeutic spend — because reducing drug utilization reduces their revenue. Employers need an independent partner.
Data-Driven Spend Analysis
We find the gaps in your healthcare spend
Alva10 analyzes your workforce claims data to surface patterns in high-cost spend — identifying where unassessed risk, screening gaps, missed primary diagnoses, and a lack of tools to predict response to high-cost therapies are the underlying drivers.
Rather than treating symptoms of high spend, we identify root causes and match your population's specific needs to diagnostic solutions that address them directly.
Diagnostics & Screening (current): 4%
Specialty & Biologic Drugs: 27%
Chronic Disease Management: 19%
Hospitalizations: 16%
Alva10 Insight:
A targeted increase in diagnostic spend — focused on primary diagnosis and risk screening in oncology and specialty drug populations — can reduce unnecessary therapeutic spend by 18–22% of total claims.
Potential spend reduction: 18–22% |
ROI on diagnostic investment: 5-10×
Oncology Therapeutics: 34%
Diagnostic Solutions
The right diagnostic at the right moment
Diagnostics are not one-size-fits-all. Not everyone has the same risk profile, not everyone needs the same management. Alva10 matches your workforce population's specific clinical profile to the most impactful diagnostic intervention.
ACCURATE DISEASE SCREENING
Accurate primary diagnosis is the foundation of effective treatment. We ensure the right diagnostic tools are available to enable diagnosis before costly interventions begin.
DISEASE SCREENING
Targeted screening changes employee health trajectories and dramatically reduces downstream costs. We implement risk-based and targeted screening tools that detect disease earlier.
RISK ASSESSMENT
Use data analytics to determine risk profiles and diagnostics to assess individual patient risk before treatment decisions are made means the right employees receive the right care. We bring validated risk stratification tools to your population.
STEP 01
Workforce Spend Analysis
We analyze your claims data to identify high-cost spending patterns, pinpoint where diagnostic gaps are the root cause, and prioritize the areas of greatest opportunity for cost reduction.
Workforce Spend Analysis
STEP 02
Diagnostic Solution Matching
Using our precision medicine technology library, we identify and curate the tools for primary diagnosis, risk assessment, and response prediction tailored to your population's specific needs.
Diagnostic Solution Matching
STEP 03
Coverage & Implementation
For fully-insured employers, we work with payers and carriers to ensure identified diagnostics are covered and accessible — so your employees can actually use them.
Coverage & Implementation
STEP 04
Outcomes Measurement
We track the clinical and economic impact of deployed diagnostic solutions — demonstrating the ROI of diagnostic investment in terms of reduced spend, improved outcomes, and workforce productivity gains.
Outcomes Measurement
Greater Workforce Productivity
Healthier employees with accurate diagnoses and effective treatments spend less time away from work — reducing absenteeism and presenteeism and improving overall productivity.
Reduced Total Cost of Care
Targeted diagnostic investment reduces unnecessary therapeutic spend, hospitalizations, and downstream treatment costs — delivering measurable savings on your healthcare benefit line.
Improved Employee Health
Accurate primary diagnosis, targeted screening, and response prediction tools mean employees receive the right treatment sooner — with fewer side effects, faster recovery, and better long-term health outcomes.
